Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 718 | 3 | 0.4 | 166 | 23.1 | 135 | 18.8 | 305 | 42.5 | 109 | 15.2 |
2015-2019 | 740 | 3 | 0.4 | 162 | 21.9 | 149 | 20.1 | 303 | 40.9 | 123 | 16.6 |
2014-2018 | 733 | 2 | 0.3 | 155 | 21.1 | 137 | 18.7 | 309 | 42.2 | 130 | 17.7 |
2013-2017 | 700 | 2 | 0.3 | 128 | 18.3 | 130 | 18.6 | 306 | 43.7 | 134 | 19.1 |
2012-2016 | 680 | 3 | 0.4 | 125 | 18.4 | 128 | 18.8 | 305 | 44.9 | 119 | 17.5 |
2011-2015 | 690 | 2 | 0.3 | 121 | 17.5 | 140 | 20.3 | 311 | 45.1 | 116 | 16.8 |
2010-2014 | 660 | 2 | 0.3 | 117 | 17.7 | 138 | 20.9 | 297 | 45.0 | 106 | 16.1 |
2009-2013 | 643 | 2 | 0.3 | 113 | 17.6 | 141 | 21.9 | 297 | 46.2 | 90 | 14.0 |
2008-2012 | 668 | 2 | 0.3 | 114 | 17.1 | 152 | 22.8 | 306 | 45.8 | 94 | 14.1 |
2007-2011 | 689 | 1 | 0.1 | 114 | 16.5 | 153 | 22.2 | 312 | 45.3 | 109 | 15.8 |
2006-2010 | 665 | 1 | 0.2 | 116 | 17.4 | 144 | 21.7 | 298 | 44.8 | 106 | 15.9 |
2005-2009 | 674 | - | - | 110 | 16.3 | 144 | 21.4 | 298 | 44.2 | 122 | 18.1 |
2004-2008 | 653 | - | - | 113 | 17.3 | 140 | 21.4 | 268 | 41.0 | 132 | 20.2 |
2003-2007 | 631 | - | - | 118 | 18.7 | 123 | 19.5 | 246 | 39.0 | 144 | 22.8 |
2002-2006 | 632 | - | - | 120 | 19.0 | 139 | 22.0 | 233 | 36.9 | 140 | 22.2 |
2001-2005 | 627 | - | - | 111 | 17.7 | 151 | 24.1 | 229 | 36.5 | 136 | 21.7 |
2000-2004 | 615 | - | - | 114 | 18.5 | 149 | 24.2 | 222 | 36.1 | 130 | 21.1 |
1999-2003 | 620 | - | - | 113 | 18.2 | 153 | 24.7 | 231 | 37.3 | 123 | 19.8 |
1998-2002 | 622 | - | - | 112 | 18.0 | 163 | 26.2 | 238 | 38.3 | 109 | 17.5 |
1997-2001 | 606 | - | - | 110 | 18.2 | 151 | 24.9 | 243 | 40.1 | 102 | 16.8 |
1996-2000 | 596 | - | - | 119 | 20.0 | 136 | 22.8 | 233 | 39.1 | 108 | 18.1 |
1995-1999 | 585 | - | - | 126 | 21.5 | 119 | 20.3 | 225 | 38.5 | 115 | 19.7 |
1994-1998 | 579 | - | - | 128 | 22.1 | 116 | 20.0 | 208 | 35.9 | 127 | 21.9 |
1993-1997 | 571 | - | - | 120 | 21.0 | 105 | 18.4 | 207 | 36.3 | 139 | 24.3 |
1992-1996 | 544 | - | - | 109 | 20.0 | 101 | 18.6 | 190 | 34.9 | 144 | 26.5 |
1991-1995 | 542 | - | - | 106 | 19.6 | 97 | 17.9 | 199 | 36.7 | 140 | 25.8 |
1990-1994 | 544 | - | - | 96 | 17.6 | 100 | 18.4 | 207 | 38.1 | 141 | 25.9 |
1989-1993 | 518 | 1 | 0.2 | 84 | 16.2 | 88 | 17.0 | 203 | 39.2 | 142 | 27.4 |
1988-1992 | 485 | 1 | 0.2 | 83 | 17.1 | 84 | 17.3 | 189 | 39.0 | 128 | 26.4 |
1987-1991 | 461 | 2 | 0.4 | 82 | 17.8 | 72 | 15.6 | 177 | 38.4 | 128 | 27.8 |
1986-1990 | 420 | 3 | 0.7 | 70 | 16.7 | 72 | 17.1 | 157 | 37.4 | 118 | 28.1 |
1985-1989 | 388 | 4 | 1.0 | 66 | 17.0 | 78 | 20.1 | 143 | 36.9 | 97 | 25.0 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |